profit from every $100 of sales.
$0$100
Solesence
$1.52+67.22% today
-7.3% in 1 year
1-year low $0.641-year high $2.29
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $59.99 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Solesence sold, what it kept, and what it did with the cash.
Sales went from $37.3 million in 2022 to $62.1 million in 2025, with $1.79 million of profit last year.
SalesProfit
Solesence vs. similar companies
Solesence grows the fastest of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Solesence | 60.0× · Expensive | ||
 Procter & Gamble | 24.5× · Fair price | ||
 L'Oréal | 39.3× · Expensive | ||
 Unilever | 13.7× · Cheap | ||
 Colgate-Palmolive | 37.2× · Expensive |
AI analysis
An AI analyst reads Solesence's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 37 | 37 | 52 | 62 | |
| 8 | 8 | 16 | 16 | |
| -2 | -4 | 5 | 2 | |
| -2 | -3 | 6 | 4 | |
| -3 | -4 | 4 | 2 | |
| -0.05 | -0.09 | 0.07 | 0.02 | |
| 22.4% | 21.0% | 30.9% | 25.9% | |
| -6.1% | -9.5% | 9.8% | 2.5% | |
| -7.0% | -11.8% | 8.1% | 2.9% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 34 | 33 | 50 | 50 |
| Cash | 2 | 2 | 1 | 1 |
| Total debt | 18 | 21 | 15 | 24 |
| Total liabilities | 28 | 31 | 35 | 32 |
| 6 | 2 | 15 | 18 | |
| 49 | 50 | 65 | 73 | |
| -7.5% | -12.1% | 13.4% | 5.3% | |
| -46.4% | -230.8% | 28.3% | 10.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -2 | -2 | 2 | -9 | |
| 3 | 1 | 5 | 2 | |
| -4 | -3 | -3 | -11 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 1 | 1 | 1 | 1 |
Valuation
- 60.0×
- –
- –
- 6.0×
- 1.7×
- –
- 35.3×
- -10.0%
- 1.7%
- 0.0%
Profitability
- 25.9%
- 2.5%
- 2.9%
- 5.9%
- 3.6%
- -0.3%
- 10.5%
- 3.6%
- 4.3%
- 6.6%
Growth
- +18.5%
- –
- −314.0%
- –
- +11.8%
Financial health
- 6.2×
- 1.38
- 48.6%
- 1.7×
- 2.07
- 0.74
- 1.24
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 11%of 669
Bottom 9%of 672
Bottom 7%of 623
Top 11%of 671
Bottom 2%of 666
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 12, 2026 | -0.01 | – | – |
| Mar 31, 2026 | 0.00 | – | – |
| Nov 11, 2025 | -0.02 | – | – |
| Jul 31, 2025 | 0.04 | – | – |
| May 5, 2025 | 0.00 | – | – |
| Mar 26, 2025 | -0.01 | – | – |
| Nov 13, 2024 | 0.04 | – | – |
| Aug 10, 2024 | 0.01 | – | – |
News
Solesence expects at least $65M in shipped and on-hand orders by year-end, while pointing to potential >20% EBITDA longer termSeeking Alpha · Nov 13, 2026SLSN's Earnings Break-Even in Q2, High Operating Costs HurtYahoo Finance · Aug 25, 2026Solesence reports Q2 resultsSeeking Alpha · Aug 19, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
12No pass
Benjamin Graham
18No pass
Philip Fisher
19No pass
Peter Lynch
56No pass
Joel Greenblatt
2No pass
Charlie Munger
7No pass
Terry Smith
21No pass
Questions about Solesence
Is Solesence a good stock to buy?
A business with weak numbers, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Solesence AI analysis
What does Solesence do?
Solésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. It is in Household & Personal Products.
Does Solesence pay a dividend?
No. Solesence does not pay a dividend at the moment.
Is Solesence stock halal?
Yes. Solesence passes our halal screen: its business is permitted and its debt is 23% of its market value, under the 30% limit. How we check
How has Solesence stock done over the past year?
Down 7.3% over the past twelve months, to $1.52. It traded between $0.64 and $2.29 and is 33.6% below its high.
Who are Solesence's competitors?
The largest listed companies in the same industry are Procter & Gamble, L'Oréal, Unilever and Colgate-Palmolive. The peers table on this page compares their profit, growth and price with Solesence's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.